The bloc has now agreed on a common purchasing of a jab and antiviral treatment to control the outbreak of the disease with a 10 percent mortality rate.
The EU will buy Danish company Bavarian Nordic’s Imvanex vaccine, which is the only company with an approved monkeypox jab.
It will also purchase Siga Technologies’ Tecovirimat antiviral treatment to help curb the spread as the outbreak rips through the continent.
The announcement was made by Sweden’s vaccine coordinator Richard Bergstrom on Friday (May 27).
He told Swedish outlet Dagens Nyheter: “After several meetings it has been decided that we will buy both vaccine and an antiviral treatment.”
While he warned that no contracts have been drawn up yet, Mr Bergstrom stressed that the situation will be addressed fast.
Mr Bergstrom said: “But it will go quickly.
“We should have a contract ready in a week or so and maybe some limited deliveries in June.”
This is a breaking story. More to follow.